EDGAR Filing Documents for 0001144204-10-033145

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001144204-10-033145

Filing Date

2010-06-11

Accepted

2010-06-11 16:58:51

Documents

Period of Report

2010-04-30

Document Format Files

Seq	Description	Document	Type	Size
1		v188009_10q.htm	10-Q	1171932
2		v188009_ex10-1.htm	EX-10.1	28816
3		v188009_ex10-2.htm	EX-10.2	44166
4		v188009_ex10-3.htm	EX-10.3	45009
5		v188009_ex10-4.htm	EX-10.4	44576
6		v188009_ex10-5.htm	EX-10.5	41899
7		v188009_ex10-6.htm	EX-10.6	41976
8		v188009_ex10-7.htm	EX-10.7	42161
9		v188009_ex31-1.htm	EX-31.1	16250
10		v188009_ex31-2.htm	EX-31.2	16057
11		v188009_ex32.htm	EX-32	8528
	Complete submission text file	0001144204-10-033145.txt		1502814

Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2

Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551

GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)